Want to see JP:9267 full AI Analyst Report?
Total Valuation
Genky DrugStores Co., Ltd. has a market cap or net worth of ¥114.82B. The enterprise value is ¥133.51K.
Market Cap¥114.82B
Enterprise Value¥133.51K
Share Statistics
Genky DrugStores Co., Ltd. has 31,042,568 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,042,568
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Genky DrugStores Co., Ltd.’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 7.36%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)7.36%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee119.85M
Profits Per Employee4.28M
Employee Count1,841
Asset Turnover1.52
Inventory Turnover6.13
Valuation Ratios
The current PE Ratio of Genky DrugStores Co., Ltd. is 14.4. Genky DrugStores Co., Ltd.’s PEG ratio is 1.17.
PE Ratio14.4
PS Ratio0.47
PB Ratio1.68
Price to Fair Value1.68
Price to FCF-32.89
Price to Operating Cash Flow14.75
PEG Ratio1.17
Income Statement
In the last 12 months, Genky DrugStores Co., Ltd. had revenue of 220.64B and earned 7.88B in profits. Earnings per share was 258.51.
Revenue220.64B
Gross Profit44.92B
Operating Income10.98B
Pretax Income11.15B
Net Income7.88B
EBITDA18.12B
Earnings Per Share (EPS)258.51
Cash Flow
In the last 12 months, operating cash flow was 7.46B and capital expenditures -9.77B, giving a free cash flow of -2.31B billion.
Operating Cash Flow7.46B
Free Cash Flow-2.31B
Free Cash Flow per Share-74.41
Dividends & Yields
Genky DrugStores Co., Ltd. pays an annual dividend of ¥6.5, resulting in a dividend yield of 0.35%
Dividend Per Share¥6.5
Dividend Yield0.35%
Payout Ratio5.03%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.46
52-Week Price Change-24.63%
50-Day Moving Average3.54K
200-Day Moving Average4.22K
Relative Strength Index (RSI)44.35
Average Volume (3m)62.69K
Important Dates
Genky DrugStores Co., Ltd. upcoming earnings date is Nov 2, 2026, TBA (Confirmed).
Last Earnings DateJul 28, 2026
Next Earnings DateNov 2, 2026
Ex-Dividend Date―
Financial Position
Genky DrugStores Co., Ltd. as a current ratio of 0.93, with Debt / Equity ratio of 64.59%
Current Ratio0.93
Quick Ratio0.35
Debt to Market Cap0.38
Net Debt to EBITDA1.75
Interest Coverage Ratio35.10
Taxes
In the past 12 months, Genky DrugStores Co., Ltd. has paid 3.28B in taxes.
Income Tax3.28B
Effective Tax Rate0.29
Enterprise Valuation
Genky DrugStores Co., Ltd. EV to EBITDA ratio is 7.43, with an EV/FCF ratio of -43.05.
EV to Sales0.61
EV to EBITDA7.43
EV to Free Cash Flow-43.05
EV to Operating Cash Flow7.93
Balance Sheet
Genky DrugStores Co., Ltd. has ¥7.87B in cash and marketable securities with ¥39.64B in debt, giving a net cash position of -¥31.77B billion.
Cash & Marketable Securities¥7.87B
Total Debt¥39.64B
Net Cash-¥31.77B
Net Cash Per Share-¥1.02K
Tangible Book Value Per Share¥2.01K
Margins
Gross margin is 20.36%, with operating margin of 4.98%, and net profit margin of 3.57%.
Gross Margin20.36%
Operating Margin4.98%
Pretax Margin5.05%
Net Profit Margin3.57%
EBITDA Margin8.21%
EBIT Margin4.98%
Analyst Forecast
The average price target for Genky DrugStores Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.89%
EPS Growth Forecast11.20%